Blood Pressure Targets and Management in Hypertension (2025 AHA/ACC Guidelines)

Blood Pressure Classification

• Normal blood pressure is defined as < 120/80 mmHg. 1
• Elevated blood pressure is defined as 120–129 mmHg systolic and < 80 mmHg diastolic. 3
• Stage 1 hypertension is defined as 130–139 mmHg systolic or 80–89 mmHg diastolic. 1
• Stage 2 hypertension is defined as ≥ 140/90 mmHg. 3

Diagnosis and Confirmation

• Blood pressure should be measured with validated automated upper‑arm cuff devices using appropriately sized cuffs. (Class I) [3][4]
• Office BP ≥ 130/85 mmHg requires confirmation with home BP monitoring (≥ 135/85 mmHg) or 24‑hour ambulatory monitoring (≥ 130/80 mmHg). (Class I) [3][4]
• At the first visit, measure BP in both arms simultaneously and use the arm with the higher reading for subsequent measurements. (Class I) [3][4]
• Confirm diagnosis by averaging multiple readings across 2–3 office visits. (Class I) [3][4]
• Cuffless devices and smartwatches should not be relied upon until they demonstrate greater precision and reliability. (Class I) 1

Treatment Targets

High‑Risk Patients

• For adults with a 10‑year cardiovascular risk ≥ 7.5 % or with established CVD, CKD, diabetes, or target‑organ damage, aim for systolic BP < 130 mmHg and encourage a systolic target < 120 mmHg when feasible; diastolic BP < 80 mmHg. (Class I) 2

Lower‑Risk Patients

• For adults with a 10‑year cardiovascular risk < 7.5 %, a systolic BP target < 130 mmHg may be reasonable, though supporting evidence is less robust (Class IIb). 2

Special Populations

• Elderly and frail patients should have individualized targets based on frailty status, with an overarching goal of < 130/80 mmHg. (Class I) [3][4]1
• Patients > 80 years may be managed with monotherapy when they have low‑risk grade 1 hypertension. (Class I) [3][4]

Lifestyle Interventions (All Adults with Elevated BP or Hypertension)

• Achieve or maintain a healthy body weight. (Class I) 1
• Follow the DASH dietary pattern. (Class I) 1
• Reduce sodium intake and increase dietary potassium. (Class I) 1
• Engage in moderate‑intensity physical activity. (Class I) 3
• Implement effective stress‑management techniques. (Class I) 1
• Limit or eliminate alcohol consumption. (Class I) 1

Pharmacologic Therapy Initiation

• Initiate immediate drug therapy for all patients with stage 2 hypertension (≥ 160/100 mmHg). (Class I) 3
• Initiate immediate drug therapy for stage 1 hypertension (140–159/90–99 mmHg) in high‑risk patients (presence of CVD, CKD, diabetes, organ damage; age 50–80 years; or 10‑year risk ≥ 7.5 %). (Class I) [3][2]
• For low‑moderate risk patients with stage 1 hypertension, begin pharmacotherapy only if BP remains ≥ 130/80 mmHg after 3–6 months of lifestyle modification. (Class IIa) [3][4]2

First‑Line Pharmacologic Therapy

Stage 2 Hypertension

• Start therapy with two first‑line agents from different classes combined in a single‑pill fixed‑dose formulation (preferred over separate pills). (Class I) 1

Stage 1 Hypertension – Race‑Based Approach

• Non‑Black patients: begin with low‑dose ACE inhibitor or ARB, add a dihydropyridine calcium‑channel blocker (DHP‑CCB), then titrate to full doses, add a thiazide/thiazide‑like diuretic, and finally consider spironolactone (or alternatives if contraindicated). (Class I) [3][4]
• Black patients: begin with low‑dose ARB + DHP‑CCB or DHP‑CCB + thiazide/thiazide‑like diuretic, then titrate to full doses, add the remaining class (diuretic or ACEI/ARB), and finally consider spironolactone (or alternatives if contraindicated). (Class I) [3][4]

Simplification Strategies

• Use once‑daily dosing whenever possible. (Class I) [3][4]
• Prefer single‑pill combinations to improve adherence. (Class I) [3][4]1
• Reserve monotherapy for low‑risk grade 1 hypertension, patients > 80 years, or frail individuals. (Class I) [3][4]

Monitoring and Follow‑Up

• Achieve target BP within 3 months of therapy initiation. (Class I) [3][4]
• Aim for a BP reduction of at least 20/10 mmHg from baseline. (Class I) [3][4]
• Home BP monitoring combined with frequent multidisciplinary team interactions using standardized protocols is essential for improving control rates. (Class I) 1
• Assess medication adherence at each visit. (Class I) [3][4]
• Refer to a hypertension specialist if BP remains uncontrolled despite appropriate therapy. (Class I) [3][4]

Team‑Based Care

• Multidisciplinary team‑based care (physicians, pharmacists, nurse practitioners, nurses, physician assistants, dietitians, community health workers, etc.) is effective in addressing medication access and structural barriers. (Class I) 1

Severe Hypertension Management

• Severe hypertension (> 180/120 mmHg) without acute target‑organ damage should be evaluated and treated in the outpatient setting with timely initiation, reinstitution, or intensification of oral antihypertensive medications, shifting away from routine emergency‑department referral. (Class I) 1

Comparison to Prior Guidelines

• The 2025 AHA/ACC guidelines recommend a universal BP target of < 130/80 mmHg (with encouragement toward < 120 mmHg systolic when feasible), which is more aggressive than the 2020 International Society of Hypertension recommendation of < 140/90 mmHg (or < 130/80 mmHg for higher‑risk patients). (Class I) [3][4]
• The intensified targets are supported by trial evidence such as SPRINT, demonstrating cardiovascular benefit from intensive BP control. (Class I) 2